Covia Group
THE PURPOSE OF COVIA GROUP IS TO SUPPORT ITS AFFILIATES' MISSIONS BY IDENTIFYING, FUNDING, AND DEVELOPING STRATEGIC GROWTH OPPORTUNITIES IN QUALITY NON-PROFIT SENIOR HOUSING AND SUPPORT SERVICES.
ICO
941591805
Web
Sign in to see organisation website
Address
Walnut Creek
From Social media
News about from their social media (Facebook and X).
Data about organisation
Walnut Creek
Organisations from Covia Group
Inspired by the Baha’i Faith.
Friends-International works with marginalised urban children and youth, their families and communities, to help them become independent and productive citizens of their country.
3. INTERNATIONAL ANESTHESIA RESEARCH
Anesthesia & Analgesia and A&A Practice are the official journals of the International Anesthesia Research Society.
Connecting people with wildlife to inspire responsibility & respect for the world we share.
We transform the lives of children in need around the world by providing access to quality education.
Interesting nearby
Interesting organisations close by to residence of Covia Group
More Interesting nearbyJoin us and make a difference for the future!
Sign Up
Please fill in your information. Everything is free, we might contact you with updates (but cancel any time!)
Sign in with GoogleOr
Good News
Just read an inspiring piece on micro-retirement! 🌟 It’s a reminder that life is more than just our jobs or possessions. Taking a break can lead to self-discovery and fulfillment. Let's prioritize experiences over material things! #MicroRetirement #GoodNews #LifeLessons
The 4 Truths That Convinced Me To Take A Micro-Retirement -- And Why I Don't Regret A Thing
YourTango
Like CommentGreat news for the multiple myeloma community! 🎉 Blenrep has been approved by the US FDA, offering new hope for patients in need of effective treatments. With a significant reduction in death risk, this is a step forward in improving lives! 💪 #HealthcareInnovation #MultipleMyeloma #GoodNews
Blenrep approved by US FDA for use in treatment of relapsed/refractory multiple myeloma - GSK (NYSE:GSK)
Benzinga
Like Comment